Chemotherapy Omission in ER+/HER2- Breast Cancer With 1-3 Positive Lymph Nodes Receiving Extended Adjuvant Abemaciclib

Conditions: Breast Cancer Interventions: Drug: 3-year abemaciclib without chemo; Drug: treatment of physician ' s choice Sponsors: Fudan University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials